CS
CMTA

Credit Suisse’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Credit Suisse’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,977
Closed -$260K – 4344
2019
Q1 		$260K Buy
+9,977
New +$186K ﹤0.01% 3664

Credit Suisse's CMTA Position: Q2 2019 in Review

Credit Suisse sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 9,977 shares — an estimated $260K sold.

Credit Suisse first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $260K in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Credit Suisse reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Credit Suisse sold 9,977 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $260K.
  • Credit Suisse first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Credit Suisse's Clementia Pharmaceuticals Inc. position peaked at $260K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.